Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostic testing is essential to identify mother-to-infant transmission of HIV. Although many benefits of decentralized early infant diagnosis have been postulated, field evaluations of point-of-care assays in high-burden areas have been lacking.

Researchers in Kenya have now demonstrated that a point-of-care test from Cepheid is substantially equivalent to a standard of care lab-based test, paving the way for more effectively delivery life-saving treatment to HIV infected babies.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.